TB & Outbreaks Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB & Outbreaks Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Asthma Therapy
Research results from National Institute of Tuberculosis and Lung Disease update knowledge of asthma therapy
April 15th, 2008
New research, 'Teophylline inhibits free oxygen radicals production by human monocytes via phosphodiesterase inhibition,' is the subject of a report. According to recent research published in the Journal of Physiology and Pharmacology, "Recent evidence suggests that theophylline, apart from bronchodilatation, derives its therapeutic activity in asthma from anti-inflammatory effects. Free oxygen radicals play important role in the perpetuation of inflammatory processes underlying bronchoconstriction and airway hyperresponsiveness in asthmatics." "In our previous studies, we have analyzed the immunomodulatory effects of theophylline on human monocyte metabolic...
Source: TB & Outbreaks Week (2008-04-15)
|
